Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19-Reply

被引：0
|
作者：
Vandebosch, An [1 ]
Sadoff, Jerald [2 ]
Douoguih, Macaya [2 ]
机构：
[1] Janssen Res & Dev, Beerse, Belgium
[2] Janssen Vaccines & Prevent, Leiden, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial
    Fong, Youyi
    McDermott, Adrian B.
    Benkeser, David
    Roels, Sanne
    Stieh, Daniel J.
    Vandebosch, An
    Le Gars, Mathieu
    Van Roey, Griet A.
    Houchens, Christopher R.
    Martins, Karen
    Jayashankar, Lakshmi
    Castellino, Flora
    Amoa-Awua, Obrimpong
    Basappa, Manjula
    Flach, Britta
    Lin, Bob C.
    Moore, Christopher
    Naisan, Mursal
    Naqvi, Muhammed
    Narpala, Sandeep
    O'Connell, Sarah
    Mueller, Allen
    Serebryannyy, Leo
    Castro, Mike
    Wang, Jennifer
    Petropoulos, Christos J.
    Luedtke, Alex
    Hyrien, Ollivier
    Lu, Yiwen
    Yu, Chenchen
    Borate, Bhavesh
    van der Laan, Lars W. P.
    Hejazi, Nima S.
    Kenny, Avi
    Carone, Marco
    Wolfe, Daniel N.
    Sadoff, Jerald
    Gray, Glenda E.
    Grinsztejn, Beatriz
    Goepfert, Paul A.
    Little, Susan J.
    de Sousa, Leonardo Paiva
    Maboa, Rebone
    Randhawa, April K.
    Andrasik, Michele P.
    Hendriks, Jenny
    Truyers, Carla
    Struyf, Frank
    Schuitemaker, Hanneke
    Douoguih, Macaya
    NATURE MICROBIOLOGY, 2022, 7 (12) : 1996 - +
  • [12] Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine
    Le Gars, Mathieu
    Hendriks, Jenny
    Sadoff, Jerry
    Ryser, Martin
    Struyf, Frank
    Douoguih, Macaya
    Schuitemaker, Hanneke
    IMMUNOLOGICAL REVIEWS, 2022, 310 (01) : 47 - 60
  • [13] Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome Reply
    Woo, Emily Jane
    Dimova, Rositsa B.
    Mba-Jonas, Adamma
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (04): : 393 - 394
  • [14] Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19
    Corchado-Garcia, Juan
    Zemmour, David
    Hughes, Travis
    Bandi, Hari
    Cristea-Platon, Tudor
    Lenehan, Patrick
    Pawlowski, Colin
    Bade, Sairam
    O'Horo, John C.
    Gores, Gregory J.
    Williams, Amy W.
    Badley, Andrew D.
    Halamka, John
    Virk, Abinash
    Swift, Melanie D.
    Wagner, Tyler
    Soundararajan, Venky
    JAMA NETWORK OPEN, 2021, 4 (11) : e2132540
  • [15] Ad26.COV2.S COVID-19 vaccine: TTS a rare, but serious adverse event
    Reactions Weekly, 2022, 1891 (1) : 2 - 2
  • [16] Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report
    Di Pietro, Martina
    Dono, Fedele
    Consoli, Stefano
    Evangelista, Giacomo
    Pozzilli, Valeria
    Calisi, Dario
    Barbone, Filomena
    Bonanni, Laura
    Onofrj, Marco
    De Angelis, Maria Vittoria
    Sensi, Stefano L.
    NEUROLOGICAL SCIENCES, 2022, 43 (05) : 2951 - 2956
  • [17] Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report
    Martina Di Pietro
    Fedele Dono
    Stefano Consoli
    Giacomo Evangelista
    Valeria Pozzilli
    Dario Calisi
    Filomena Barbone
    Laura Bonanni
    Marco Onofrj
    Maria Vittoria De Angelis
    Stefano L. Sensi
    Neurological Sciences, 2022, 43 : 2951 - 2956
  • [18] Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
    Galit Alter
    Jingyou Yu
    Jinyan Liu
    Abishek Chandrashekar
    Erica N. Borducchi
    Lisa H. Tostanoski
    Katherine McMahan
    Catherine Jacob-Dolan
    David R. Martinez
    Aiquan Chang
    Tochi Anioke
    Michelle Lifton
    Joseph Nkolola
    Kathryn E. Stephenson
    Caroline Atyeo
    Sally Shin
    Paul Fields
    Ian Kaplan
    Harlan Robins
    Fatima Amanat
    Florian Krammer
    Ralph S. Baric
    Mathieu Le Gars
    Jerald Sadoff
    Anne Marit de Groot
    Dirk Heerwegh
    Frank Struyf
    Macaya Douoguih
    Johan van Hoof
    Hanneke Schuitemaker
    Dan H. Barouch
    Nature, 2021, 596 : 268 - 272
  • [19] Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
    Alter, Galit
    Yu, Jingyou
    Liu, Jinyan
    Chandrashekar, Abishek
    Borducchi, Erica N.
    Tostanoski, Lisa H.
    McMahan, Katherine
    Jacob-Dolan, Catherine
    Martinez, David R.
    Chang, Aiquan
    Anioke, Tochi
    Lifton, Michelle
    Nkolola, Joseph
    Stephenson, Kathryn E.
    Atyeo, Caroline
    Shin, Sally
    Fields, Paul
    Kaplan, Ian
    Robins, Harlan
    Amanat, Fatima
    Krammer, Florian
    Baric, Ralph S.
    Le Gars, Mathieu
    Sadoff, Jerald
    de Groot, Anne Marit
    Heerwegh, Dirk
    Struyf, Frank
    Douoguih, Macaya
    van Hoof, Johan
    Schuitemaker, Hanneke
    Barouch, Dan H.
    NATURE, 2021, 596 (7871) : 268 - +
  • [20] Rhabdomyolysis Following Ad26.COV2.S COVID-19 Vaccination
    Gelbenegger, Georg
    Cacioppo, Filippo
    Firbas, Christa
    Jilma, Bernd
    VACCINES, 2021, 9 (09)
12345